Prevail是一家生物技术公司,致力于为神经退行性疾病患者开发潜在的基于疾病改良AAV9的基因疗法。#生物医药下一个十年# #AAV基因治疗#查看全文
消灵通2020-12-15 22:44
$Prevail Therapeutics(PRVL)$ $礼来(LLY)$ 礼来上涨2%,Prevail Therapeutics飙涨83%;礼来宣布以8.8亿美元或每股22.5美元的价格收购Prevail Therapeutics。查看全文
牛唐2020-12-15 21:55
$礼来(LLY)$ Buy $Prevail Therapeutics(PRVL)$ for $22.50/Share in Cash ,一天一个并购,$美国生科ETF-SPDR(XBI)$ 又要嗨了查看全文
华尔街操盘手_2019-06-21 00:15
$Slack Technologies(WORK)$ $Grocery Outlet(GO)$ $Prevail Therapeutics(PRVL)$ 最全ipo上市列表 网页链接查看全文
$Prevail Therapeutics(PRVL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-018121 Size: 5 KB 网页链接
$Prevail Therapeutics(PRVL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-018123 Size: 5 KB 网页链接
$Prevail Therapeutics(PRVL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-018129 Size: 5 KB 网页链接
$Prevail Therapeutics(PRVL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-018133 Size: 5 KB 网页链接
$Prevail Therapeutics(PRVL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-018117 Size: 7 KB 网页链接
$Prevail Therapeutics(PRVL)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001193125-20-059726 Act: 34 Size: 12 MB 网页链接
$Prevail Therapeutics(PRVL)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-20-021902 Act: 34 Size: 59 KB 网页链接
$Prevail Therapeutics(PRVL)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-20-000149 Act: 34 Size: 46 KB 网页链接
$Prevail Therapeutics(PRVL)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-20-035774 Act: 34 Size: 47 KB 网页链接
$Prevail Therapeutics(PRVL)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-20-035624 Act: 34 Size: 40 KB 网页链接